Jennifer Jarrett, the Chief Operating Officer of $RCUS, sold 12,500 shares of the company on 10-06-2025 for an estimated $181,801. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.5% of their shares of this class of stock. Following this trade, they now own 214,232 shares of this class of $RCUS stock.
$RCUS Insider Trading Activity
$RCUS insiders have traded $RCUS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $RCUS stock by insiders over the last 6 months:
- JENNIFER JARRETT (Chief Operating Officer) has made 0 purchases and 2 sales selling 50,292 shares for an estimated $750,412.
- ALEXANDER AZOY (Chief Accounting Officer) has made 0 purchases and 2 sales selling 4,410 shares for an estimated $55,561.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RCUS Hedge Fund Activity
We have seen 106 institutional investors add shares of $RCUS stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 3,099,567 shares (+108.1%) to their portfolio in Q2 2025, for an estimated $25,230,475
- FMR LLC removed 1,883,552 shares (-42.3%) from their portfolio in Q2 2025, for an estimated $15,332,113
- SUVRETTA CAPITAL MANAGEMENT, LLC added 1,127,954 shares (+44.0%) to their portfolio in Q2 2025, for an estimated $9,181,545
- WOODLINE PARTNERS LP removed 1,127,275 shares (-22.0%) from their portfolio in Q2 2025, for an estimated $9,176,018
- MORGAN STANLEY added 682,724 shares (+86.7%) to their portfolio in Q2 2025, for an estimated $5,557,373
- DECHENG CAPITAL LLC removed 648,789 shares (-80.2%) from their portfolio in Q2 2025, for an estimated $5,281,142
- PARKMAN HEALTHCARE PARTNERS LLC removed 616,019 shares (-50.7%) from their portfolio in Q2 2025, for an estimated $5,014,394
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RCUS Analyst Ratings
Wall Street analysts have issued reports on $RCUS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/07/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
- Barclays issued a "Overweight" rating on 04/23/2025
To track analyst ratings and price targets for $RCUS, check out Quiver Quantitative's $RCUS forecast page.
$RCUS Price Targets
Multiple analysts have issued price targets for $RCUS recently. We have seen 5 analysts offer price targets for $RCUS in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Asthika Goonewardene from Truist Securities set a target price of $39.0 on 10/07/2025
- Eva Fortea Verdejo from Wells Fargo set a target price of $25.0 on 08/07/2025
- Terence Flynn from Morgan Stanley set a target price of $22.0 on 05/09/2025
- Salveen Richter from Goldman Sachs set a target price of $13.0 on 05/08/2025
- Peter Lawson from Barclays set a target price of $14.0 on 04/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
